University of Glasgow campus

Health Sciences

PhD Molecular Pharmacology at University of Glasgow

University of Glasgow, United Kingdom

Programme overview

Research focuses on the structure and function of G protein-coupled receptors (GPCRs) and the signalling pathways important for physiological and pathophysiological responses, using pharmacological analysis, cell signalling, drug discovery and transgenic and disease mouse models.

Faculty: College of Medical, Veterinary and Life Sciences  |  Duration: 3-4 years full-time; 5 years part-time  |  Location: Glasgow, Scotland, United Kingdom

What you will study

Individual research project tailored around the expertise of principal investigators, covering training in molecular pharmacology, cell signalling and drug discovery.

Official programme page

Application information

Entry requirements

Usually a 2.1 honours degree with a significant component in Life Science, Biomedical Science or Physical Science. Required documents: academic transcripts and degree certificates, CV, MVLS cover letter, two references. International applicants from non-English-speaking countries: IELTS Academic 7.0 overall with no subtest below 6.5 (other accepted tests include TOEFL iBT, PTE Academic (test centre) and Cambridge C1/C2).

International applicants: GBP 33,708 a year (2027/28). 2027/28 full-time annual tuition (international and EU). UK fee for 2027/28 to be confirmed (2026/27 UK fee was GBP 5,238). Part-time study is charged at half the full-time annual fee. Excludes possible bench fees (research support costs) set in the offer Source

Intake: September

Duration: 3-4 years full-time; 5 years part-time

Explore more study programmes

Health Sciences

BN Nursing

University of Glasgow, United Kingdom

Degree
Bachelor's
Next intake
September 2027

View all study programmes →

Ready to start your study abroad journey?

Book a free consultation with our expert counsellors and take the first step towards your dream university.

Copyrights © 2026 StudyMapped. All rights reserved.